Evidence map›Paper›PMID 33945821›Full record

ArticleAmerican journal of ophthalmology2021

The Association between QuantiFERON-TB Gold Test and Clinical Manifestations of Uveitis in the United States.

Mehmet Yakin, Natasha Kesav, Shuk Kei Cheng, Sonny Caplash, Sapna Gangaputra, H Nida Sen

Open access · greenAbstract read
In one paragraph

Article in American journal of ophthalmology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 14 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Mehmet YakinFrom the National Eye Institute, National Institutes of Health, Bethesda, MD (M.Y, N.K, S.K.C, S.C, H.N.S).
Natasha KesavFrom the National Eye Institute, National Institutes of Health, Bethesda, MD (M.Y, N.K, S.K.C, S.C, H.N.S).
Shuk Kei ChengFrom the National Eye Institute, National Institutes of Health, Bethesda, MD (M.Y, N.K, S.K.C, S.C, H.N.S).
Sonny CaplashFrom the National Eye Institute, National Institutes of Health, Bethesda, MD (M.Y, N.K, S.K.C, S.C, H.N.S).
Sapna GangaputraVanderbilt Eye Institute, Nashville, TN, USA (S.G).
H Nida SenFrom the National Eye Institute, National Institutes of Health, Bethesda, MD (M.Y, N.K, S.K.C, S.C, H.N.S). Electronic address: senh@nei.nih.gov.
National Institutes of Health · USVanderbilt Health · US

Funding

Studies of Ocular inflammation: Translational ResearchZIAEY000556 · NEI · NATIONAL EYE INSTITUTE · PI CASPI, RACHEL R. · 2017 to 2025
$11.3M
Uveitis and Ocular Immunology FellowshipZIEEY000482 · NEI · NATIONAL EYE INSTITUTE · PI KODATI, SHILPA · 2009 to 2022
$4.6M
Studies of Ocular inflammation: Clinical researchZIAEY000557 · NEI · NATIONAL EYE INSTITUTE · PI SEN, HATICE · 2017 to 2018
$2.0M
Intramural NIH HHS ZIA EY000556Intramural NIH HHS ZIA EY000557Intramural NIH HHS ZIE EY000482
6 · The paper itself

Abstract

purposeTo report the prevalence of QuantiFERON-TB Gold (QFT-G) positivity among uveitis patients compared to general population and to evaluate the differences in clinical features of uveitis.

designRetrospective cohort study.

methods

settingInstitutional. PATIENT POPULATION: 418 consecutive new uveitis patients, regardless of clinical suspicion, were tested for QFT-G. OBSERVATION PROCEDURES: Demographics, TB risk factors, clinical characteristics of uveitis were collected.

main outcome measuresThe frequency of QFT-G positivity among uveitis patients and characteristic clinical features among QFT-G positive patients.

resultsQFT-G positivity was found in 60/418 patients with uveitis (14.4%, 95% CI: 11.18 - 18.14) higher than the general US population (5%, 95% CI: 4.2 - 5.8, p<.001). Age, gender and residence were similar between QFT-G positive and negative groups. Uveitis patients with positive QFT-G were more likely to be foreign born or have a recent travel history (OR:5.84; 95% CI: 2.83 - 12.05; p<.001). QFT-G positive patients were more likely to present with granulomatous uveitis (OR 2.90; 95%CI 1.36 - 6.21; p=.006). No significant association was found with specific clinical features such as choroiditis, retinal vasculitis, occlusive vasculitis, and serpiginoid choroiditis (p>.05 for each). Prevalence of TB-uveitis based on treatment response was 1.19%.

conclusionsOur study demonstrates significantly higher prevalence of QFT-G positivity among uveitis patients compared to average US population. Characteristic signs of TB uveitis reported in endemic countries were not seen in this cohort. Implications of higher prevalence of QFT-G positivity among uveitis patients require further investigation.

Indexed as

ChoroiditisTuberculosis, OcularUveitisHumansInterferon-gamma Release TestsRetrospective StudiesTuberculin TestUnited States

Identifiers

PMID33945821
PMCPMC8560650
OpenAlexW3159404151

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.